Literature DB >> 24882256

Toxoplasmosis in patients with hematologic malignancies.

Ashish Chintakuntlawar1, Michael Kidd, Aref Al-Kali, Walter Wilson, Carrie A Thompson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24882256     DOI: 10.3109/10428194.2014.926348

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  5 in total

1.  Association between Toxoplasma gondii exposure and paediatrics haematological malignancies: a case-control study.

Authors:  Narges Kalantari; Javad Rezanejad; Ahmad Tamadoni; Salman Ghaffari; Jaber Alipour; Masomeh Bayani
Journal:  Epidemiol Infect       Date:  2018-08-10       Impact factor: 4.434

2.  Anti-Toxoplasma gondii antibodies in patients with beta-hemoglobinopathies: the first report in the Americas.

Authors:  Marina Neves Ferreira; Claudia Regina Bonini-Domingos; Isabeth Fonseca Estevão; Clarice Lopes de Castro Lobo; Gisele Cristina Souza Carrocini; Aparecida Perpétuo Silveira-Carvalho; Octávio Ricci; Luiz Carlos de Mattos; Cinara Cássia Brandão de Mattos
Journal:  BMC Res Notes       Date:  2017-06-14

3.  Serological Evaluation of Anti-Toxoplasma gondii Antibodies in Patients with Acute Leukemia and Lymphoma through Chemotherapy.

Authors:  Fatemeh Tabatabaie; Taher Elmi; Majid Khanmohammadi; Lame Akhlaghi; Mahmoud Mahami-Oskouei; Mehdi Arshadi
Journal:  Iran J Parasitol       Date:  2020 Apr-Jun       Impact factor: 1.012

4.  Acute Toxoplasma Dissemination With Encephalitis in the Era of Biological Therapies.

Authors:  Amal A Gharamti; Amy Rao; Paula E Pecen; Andrés F Henao-Martínez; Carlos Franco-Paredes; José G Montoya
Journal:  Open Forum Infect Dis       Date:  2018-10-17       Impact factor: 3.835

5.  Seroprevalence and risk factors of Toxoplasma gondii infection in oral cancer patients in China: a case-control prospective study.

Authors:  N Zhou; X Y Zhang; Y X Li; L Wang; L L Wang; W Cong
Journal:  Epidemiol Infect       Date:  2018-07-13       Impact factor: 4.434

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.